Sunshine Biopharma, Inc. ( SBFMW) - Key Metrics
SBFMW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $2.02 | -$0.19 | -$0.16 | -$0.16 |
| 2025Q2 | $41.86 | -$7.88 | -$5.66 | -$8.11 |
| 2025Q1 | $3.29 | -$0.44 | -$0.63 | -$0.71 |
SBFMW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.96 |
| 2025Q2 | ? | -0.05 |
| 2025Q1 | ? | -1.09 |
SBFMW
Price: $0.05
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 392476